你即將離開本站

並前往https://www.thelancet.com/article/S1470-2045(21)00567-2/fulltext

ESMO Congress 2021 - The Lancet Oncology

ESMO Congress 2021 · Phase 2 NORSE study · Relacorilant for ovarian cancer · Tanezumab for cancer-related pain · DESTINY-Breast03 trial.

確定！ 回上一頁

查詢 「ESMO 2021」的人也找了：

  1. esmo 2022
    2.
  2. ESMO 2020
    3.
  3. esmo 2023
    4.
  4. Capdevila j et al presented at esmo 2021 abstract lba67
    5.
  5. asco 2021
    6.
  6. ESMO Asia 2023
    7.
  7. ESMO 2022 program
    8.
  8. ESMO 2022 Congress
    9.